Cargando…

NTBC Treatment Monitoring in Chilean Patients with Tyrosinemia Type 1 and Its Association with Biochemical Parameters and Liver Biomarkers

Treatment and follow-up in Hereditary Tyrosinemia type 1 (HT-1) patients require comprehensive clinical and dietary management, which involves drug therapy with NTBC and the laboratory monitoring of parameters, including NTBC levels, succinylacetone (SA), amino acids, and various biomarkers of liver...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fuenzalida, Karen, Leal-Witt, María Jesús, Guerrero, Patricio, Hamilton, Valerie, Salazar, María Florencia, Peñaloza, Felipe, Arias, Carolina, Cornejo, Verónica
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8706240/ https://www.ncbi.nlm.nih.gov/pubmed/34945128 http://dx.doi.org/10.3390/jcm10245832

Ejemplares similares

Neurological Crises after Discontinuation of Nitisinone (NTBC) Treatment in Tyrosinemia
por: HONAR, Naser, et al.
Publicado: (2017)

Blood and Brain Biochemistry and Behaviour in NTBC and Dietary Treated Tyrosinemia Type 1 Mice
por: van Ginkel, Willem G., et al.
Publicado: (2019)

Experience of a Single Center in NTBC Use in Management of Hereditary Tyrosinemia Type I in Libya
por: Alobaidy, Hanna, et al.
Publicado: (2015)

Emotional and behavioral problems, quality of life and metabolic control in NTBC-treated Tyrosinemia type 1 patients
por: van Vliet, Kimber, et al.
Publicado: (2019)

Daily variation of NTBC and its relation to succinylacetone in tyrosinemia type 1 patients comparing a single dose to two doses a day
por: Kienstra, Nienke S., et al.
Publicado: (2017)

Risk of Developing Insulin Resistance in Adult Subjects with Phenylketonuria: Machine Learning Model Reveals an Association with Phenylalanine Concentrations in Dried Blood Spots
por: Leal-Witt, María Jesús, et al.
Publicado: (2023)

Muscle and Bone Health in Young Chilean Adults with Phenylketonuria and Different Degrees of Compliance with the Phenylalanine Restricted Diet
por: Rojas-Agurto, Eugenia, et al.
Publicado: (2023)

Hepatorenal tyrosinemia
por: KITAGAWA, Teruo
Publicado: (2012)

Antimicrobial Properties of Chilean Native Plants: Future Aspects in Their Application in the Food Industry
por: Otero, María Carolina, et al.
Publicado: (2022)

Anti-Inflammatory Chilean Endemic Plants
por: Otero, Carolina, et al.
Publicado: (2023)

Long-term cognitive functioning in individuals with tyrosinemia type 1 treated with nitisinone and protein-restricted diet
por: García, María Ignacia, et al.
Publicado: (2017)

Syndrome of hereditary tyrosinemia in mink
por: Christensen, K, et al.
Publicado: (1978)

Treatment adherence in tyrosinemia type 1 patients
por: González-Lamuño, Domingo, et al.
Publicado: (2021)

Comment on Pancreatitis in Type 1 Tyrosinemia
por: Rahmoune, Hakim, et al.
Publicado: (2017)

Tyrosinemia type III in an asymptomatic girl
por: Szymanska, Edyta, et al.
Publicado: (2015)

Adenine base editing in an adult mouse model of tyrosinemia
por: Song, Chun-Qing, et al.
Publicado: (2019)

Neonatal hyperinsulinism in transient and classical forms of tyrosinemia
por: Sethuram, Swathi, et al.
Publicado: (2021)

NTBC Treatment of the Pyomelanogenic Pseudomonas aeruginosa Clinical Isolate PA1111 Inhibits Pigment Production and Increases Sensitivity to Oxidative Stress
por: M. Ketelboeter, Laura, et al.
Publicado: (2014)

Hereditary tyrosinemia. Formation of succinylacetone-amino acid adducts
Publicado: (1985)

Type 1 tyrosinemia in Finland: a nationwide study
por: Äärelä, Linnea, et al.
Publicado: (2020)

Protein Degradation and the Pathologic Basis of Phenylketonuria and Hereditary Tyrosinemia
por: Sarodaya, Neha, et al.
Publicado: (2020)

Novel Mutation of Tyrosinemia in a Child With Hypophosphatemic Rickets
por: Dogra, Surabhi, et al.
Publicado: (2022)

Case report: ADHD and prognosis in tyrosinemia type 1
por: Barone, Helene, et al.
Publicado: (2023)

Erratum to: NTBC Treatment of the Pyomelanogenic Pseudomonas aeruginosa Clinical Isolate PA1111 Inhibits Pigment Production and Increases Sensitivity to Oxidative Stress
por: Ketelboeter, Laura M., et al.
Publicado: (2014)

Evolution of tyrosinemia type 1 disease in patients treated with nitisinone in Spain
por: Couce, María Luz, et al.
Publicado: (2019)

Severe neurological crisis in adult patients with Tyrosinemia type 1
por: Dawson, Charlotte, et al.
Publicado: (2020)

Revisiting hereditary tyrosinemia Type 1—spectrum of radiological findings
por: Shaikh, Sana, et al.
Publicado: (2018)

Casein Glycomacropeptide: An Alternative Protein Substitute in Tyrosinemia Type I
por: Daly, Anne, et al.
Publicado: (2021)

Hereditary Tyrosinemia Type 1 in Jordan: A Retrospective Study
por: Megdadi, Noor A., et al.
Publicado: (2021)

In vivo quantitative photoacoustic evaluation of the liver and kidney pathology in tyrosinemia
por: Huang, Guojia, et al.
Publicado: (2022)

Clostridium difficile infection in Chilean patients submitted to hematopoietic stem cell transplantation
por: Pilcante, Javier, et al.
Publicado: (2015)

First-year metabolic control guidelines and their impact on future metabolic control and neurocognitive functioning in children with PKU
por: de la Parra, Alicia, et al.
Publicado: (2017)

Clinical and Para Clinical Findings in the Children with Tyrosinemia Referring for Liver Transplantation
por: Dehghani, Seyed Mohsen, et al.
Publicado: (2013)

Neurocognitive outcome in tyrosinemia type 1 patients compared to healthy controls
por: van Ginkel, Willem G., et al.
Publicado: (2016)

A Case of Tyrosinemia Type III with Status Epilepticus and Mental Retardation
por: Najafi, Reza, et al.
Publicado: (2018)

TYROSINEMIA TYPE III: A CASE REPORT OF SIBLINGS AND LITERATURE REVIEW
por: Barroso, Fábio, et al.
Publicado: (2020)

Therapeutic Targeting of Fumaryl Acetoacetate Hydrolase in Hereditary Tyrosinemia Type I
por: Gil-Martínez, Jon, et al.
Publicado: (2021)

Clinical experience with hepatorenal tyrosinemia from a single Egyptian center
por: El-Karaksy, Hanaa, et al.
Publicado: (2022)

Anticoagulation Management With Coumarinic Drugs in Chilean Patients
por: Nieto, Elena, et al.
Publicado: (2019)

Molecular basis of various forms of maple syrup urine disease in Chilean patients
por: Campanholi, Diana Ruffato Resende, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_c8v68srfq2u370558t3mbtntfk